Stylianou, C. E., Wiggins, G. A. R., Lau, V. L., Dennis, J., Shelling, A. N., Wilson, M., Sykes, P., … Pearson, J., & Walker, L. C. (2024). Germline copy number variants and endometrial cancer risk. Human Genetics, 143, 1481-1498. doi: 10.1007/s00439-024-02707-9
Journal - Research Article
Lau, A. W. K., Lau, V. L., & Sakowska, M. M. (2023). Evolution of sentinel lymph node biopsy for breast cancer patients in a rural setting: 10 years' experience. New Zealand Medical Journal/Te ara tika o te hauora hapori, 136(1575), 42-49. Retrieved from https://journal.nzma.org.nz/
Journal - Research Article
Lattimore, V., Parsons, M. T., Spurdle, A. B., Pearson, J., Lehnert, K., Sullivan, J., … Morrin, H., Robinson, B., & Walker, L. (2021). Under-ascertainment of breast cancer susceptibility gene carriers in a cohort of New Zealand female breast cancer patients. Breast Cancer Research & Treatment, 185, 583-590. doi: 10.1007/s10549-020-05986-8
Journal - Research Article
Lattimore, V., Parsons, M., Spurdle, A., Pearson, J., Northcott, H., Lehnert, K., … Morrin, H., Robinson, B., & Walker, L. (2020). Potential under-ascertainment of New Zealand women at high-risk of breast cancer in clinical care [Invited]. Proceedings of the Genetics Otago (GO) Zoom Symposium. Retrieved from https://blogs.otago.ac.nz/go/2020-3/
Conference Contribution - Published proceedings: Abstract
Walker, L. C., Lattimore, V. L., Kvist, A., Kleiblova, P., Zemankova, P., de Jong, L., Wiggins, G. A. R., Hakkaart, C., Cree, S. L., … Kennedy, M. A., … de la Hoya, M. (2019). Comprehensive assessment of BARD1 messenger ribonucleic acid splicing with implications for variant classification. Frontiers in Genetics, 10, 1139. doi: 10.3389/fgene.2019.01139
Journal - Research Article
2024
Journal - Research Article
Stylianou, C. E., Wiggins, G. A. R., Lau, V. L., Dennis, J., Shelling, A. N., Wilson, M., Sykes, P., … Pearson, J., & Walker, L. C. (2024). Germline copy number variants and endometrial cancer risk. Human Genetics, 143, 1481-1498. doi: 10.1007/s00439-024-02707-9
2023
Journal - Research Article
Lau, A. W. K., Lau, V. L., & Sakowska, M. M. (2023). Evolution of sentinel lymph node biopsy for breast cancer patients in a rural setting: 10 years' experience. New Zealand Medical Journal/Te ara tika o te hauora hapori, 136(1575), 42-49. Retrieved from https://journal.nzma.org.nz/
2021
Journal - Research Article
Lattimore, V., Parsons, M. T., Spurdle, A. B., Pearson, J., Lehnert, K., Sullivan, J., … Morrin, H., Robinson, B., & Walker, L. (2021). Under-ascertainment of breast cancer susceptibility gene carriers in a cohort of New Zealand female breast cancer patients. Breast Cancer Research & Treatment, 185, 583-590. doi: 10.1007/s10549-020-05986-8
2020
Conference Contribution - Published proceedings: Abstract
Lattimore, V., Parsons, M., Spurdle, A., Pearson, J., Northcott, H., Lehnert, K., … Morrin, H., Robinson, B., & Walker, L. (2020). Potential under-ascertainment of New Zealand women at high-risk of breast cancer in clinical care [Invited]. Proceedings of the Genetics Otago (GO) Zoom Symposium. Retrieved from https://blogs.otago.ac.nz/go/2020-3/
2019
Journal - Research Article
Walker, L. C., Lattimore, V. L., Kvist, A., Kleiblova, P., Zemankova, P., de Jong, L., Wiggins, G. A. R., Hakkaart, C., Cree, S. L., … Kennedy, M. A., … de la Hoya, M. (2019). Comprehensive assessment of BARD1 messenger ribonucleic acid splicing with implications for variant classification. Frontiers in Genetics, 10, 1139. doi: 10.3389/fgene.2019.01139
Parsons, M. T., Tudini, E., Li, H., Hahnen, E., Wappenschmidt, B., Feliubadaló, L., … Lattimore, V. L., … Spurdle, A. B. (2019). Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification. Human Mutation, 40, 1557-1578. doi: 10.1002/humu.23818
Lopez-Perolio, I., Leman, R., Behar, R., Lattimore, V., Pearson, J. F., Castéra, L., … Walker, L. C., … de la Hoya, M. (2019). Alternative splicing and ACMG-AMP-2015-based classification of PALB2 genetic variants: An ENIGMA report. Journal of Medical Genetics, 56, 453-460. doi: 10.1136/jmedgenet-2018-105834
Lattimore, V. L., Pearson, J. F., Morley-Bunker, A. E., kConFab Investigators, Spurdle, A. B., Robinson, B. A., Currie, M. J., & Walker, L. C. (2019). Quantifying BRCA1 and BRCA2 mRNA isoform expression levels in single cells. International Journal of Molecular Sciences, 20(3), 693. doi: 10.3390/ijms20030693
Brandão, R. D., Mensaert, K., López-Perolio, I., Tserpelis, D., Xenakis, M., Lattimore, V., Walker, L. C., … Blok, M. J. (2019). Targeted RNA-seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genes. International Journal of Cancer, 145, 401-414. doi: 10.1002/ijc.32114
2018
Journal - Research Article
Lattimore, V. L., Pearson, J. F., Currie, M. J., Spurdle, A. B., kConFab Investigators, Robinson, B. A., & Walker, L. C. (2018). Investigation of experimental factors that underlie BRCA1/2 mRNA isoform expression variation: Recommendations for utilising targeted RNA sequencing to evaluate potential spliceogenic variants. Frontiers in Oncology, 8, 140. doi: 10.3389/fonc.2018.00140
Conference Contribution - Published proceedings: Abstract
Lattimore, V., Lehnert, K., Lintott, C., Sullivan, J., Morrin, H., Robinson, B., & Walker, L. (2018). Evaluating variants in breast cancer associated genes identified by panel sequencing of New Zealand breast cancer patients. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/
Conference Contribution - Poster Presentation (not in published proceedings)
Lattimore, V. L., Lehnert, K., Lintott, C., Sullivan, J., Morrin, H., Robinson, B., & Walker, L. C. (2018, August). Evaluating variants in breast cancer associated genes identified by panel sequencing of New Zealand breast cancer patients. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
2017
Journal - Research Article
de Jong, L. C., Cree, S., Lattimore, V., Wiggins, G. A. R., Spurdle, A. B., kConFab Investigators, Miller, A., Kennedy, M. A., & Walker, L. C. (2017). Nanopore sequencing of full-length BRCA1 mRNA transcripts reveals co-occurrence of known exon skipping events. Breast Cancer Research, 19, 127. doi: 10.1186/s13058-017-0919-1
Awarded Doctoral Degree
Lattimore, V. (2017). Genetic variation and mRNA splicing in familial breast cancer genes (PhD). University of Otago, Dunedin, New Zealand. Retrieved from http://hdl.handle.net/10523/7319
2016
Journal - Research Article
de la Hoya, M., Soukarieh, O., López-Perolio, I., Vega, A., Walker, L. C., van Ierland, Y., … Lattimore, V., … Spurdle, A. B. (2016). Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms. Human Molecular Genetics, 25(11), 2256-2268. doi: 10.1093/hmg/ddw094
2015
Journal - Research Other
Lattimore, V., Currie, M., Lintott, C., Sullivan, J., Robinson, B. A., & Walker, L. C. (2015). Meeting the challenges of interpreting variants of unknown clinical significance in BRCA testing. New Zealand Medical Journal, 128(1419). Retrieved from http://www.nzma.org.nz/journal
Conference Contribution - Published proceedings: Abstract
Lattimore, V., Pearson, J., Currie, M., Robinson, B., & Walker, L. (2015). Evaluating BRCA1 and BRCA2 sequence variants that modulate isoform expression. New Zealand Medical Journal, 128(1421). Retrieved from https://www.nzma.org.nz/journal
Conference Contribution - Verbal presentation and other Conference outputs
Lattimore, V., Pearson, J. F., Currie, M., Robinson, B. A., Spurdle, A. B., & Walker, L. C. (2015, August-September). Using splicing assays to interpret variants of unknown clinical significance in BRCA1 and BRCA2. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
2014
Journal - Research Article
Whiley, P. J., de la Hoya, M., Thomassen, M., Becker, A., Brandão, R., Sokilde Pedersen, I., … Lattimore, V., … Walker, L., … on behalf of the ENIGMA consortium. (2014). Comparison of mRNA splicing assay protocols across multiple laboratories: Recommendations for best practice in standardized clinical testing. Clinical Chemistry, 60(2), 341-352. doi: 10.1373/clinchem.2013.210658
Conference Contribution - Poster Presentation (not in published proceedings)
Lattimore, V., Currie, M., Robinson, B., kConFab Investigators, & Walker, L. (2014, September). Evaluating BRCA1 and BRCA2 sequence variants that modulate isoform expression. Poster session presented at the Division of Health Sciences Research Forum: Learning Different Research Languages, Dunedin, New Zealand.
Conference Contribution - Verbal presentation and other Conference outputs
Lattimore, V. (2014, October). Evaluating BRCA1 and BRCA2 sequence variants that modulate isoform expression. Verbal presentation at the New Zealand Society for Oncology (NZSO) Conference, Tauranga, New Zealand.
2013
Conference Contribution - Published proceedings: Abstract
Lattimore, V., Currie, M., Robinson, B., kConFab Investigators, Spurdle, A., & Walker, L. (2013). Evaluating BRCA1 and BRCA2 sequence variants that modulate isoform expression. New Zealand Medical Journal, 126(1375). Retrieved from http://www.nzma.org.nz/journal
Conference Contribution - Poster Presentation (not in published proceedings)
Lattimore, V., Currie, M., Robinson, B., kConFab Investigators, Spurdle, A., & Walker, L. (2013, September). Elevating BRCA1 and BRCA2 sequence variants that modulate isoform expression. Poster session presented at the Division of Health Sciences Research Forum: Foundations for Health: Otago Health Research, Christchurch, New Zealand.
2012
Conference Contribution - Poster Presentation (not in published proceedings)
Lattimore, V., Robinson, B., Currie, M., & Walker, L. (2012, September). Evaluating BRCA1 and BRCA2 sequence variants that modulate isoform expression. Poster session presented at the Division of Health Sciences Research Forum: Health Matters: Research Excellence at Otago, Dunedin, New Zealand.
